Citigroup’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History
Bought
Maintained
Sold
Other funds holding CELGZ
CC
FA
BC
DC
JMPWA
CL
Citigroup's CELGZ Position: Q1 2016 in Review
Citigroup sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q1 2016, closing a stake of 160 shares.
Citigroup first reported a position in CELGZ in Q2 2013 and held it in 11 quarters. The position peaked at $195K in Q3 2013. 25 funds tracked by Wall St. Rank hold CELGZ as of Q1 2016.
- Citigroup reported no remaining Celgene Corporation Contingent Value Rights position as of Q1 2016 after selling out during the quarter.
- Citigroup sold 160 Celgene Corporation Contingent Value Rights shares in Q1 2016.
- Citigroup first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 11 quarters.
- Citigroup's Celgene Corporation Contingent Value Rights position peaked at $195K in Q3 2013.
- 25 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q1 2016.
Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.